About us
A professional peptide manufacturer with reliable global‑trade service.
Who we are
With us, expect more than just a peptide supplier.
Pepvita Biotech is a direct‑source peptide manufacturer. We focus on research‑grade lyophilized peptides, custom peptide synthesis and bulk wholesale. Every batch comes with complete COA reports and third‑party test data to guarantee consistent high purity for global laboratories and wholesale partners.
Custom Project Planning
Confirm your peptide specifications, purity and batch scale to build your production plan.
Controlled Synthesis
Standardized peptide synthesis with strict in‑line quality monitoring throughout production.
Complete Quality Proof
Every batch is tested, with COA and third‑party reports delivered prior to dispatch.
Standard Peptide Supply
Wide catalog of ready‑to‑ship lyophilized research peptides with full batch COA documentation.
Bulk Wholesale Service
Large‑volume bulk orders with competitive pricing, tailored for research institutions and distributors.
Custom Peptide Synthesis
Custom‑order peptides with variable purity, scale and modification for your laboratory projects.
Global Logistics Support
Safe cold‑chain packaging and worldwide shipping, complete customs‑friendly documentation.
Our services
We Boost Our Client’s Success.
We supply high‑purity research‑grade peptides, custom peptide synthesis and reliable global logistics solutions for laboratories and wholesale partners worldwide.
Our vision
Quality, Trust & Partnership.
We strive to become a trusted global peptide manufacturing partner. We deliver reliable high‑purity peptide products, transparent testing data and efficient support for research institutions and wholesale clients worldwide.
Reliable Peptide Quality
Strict synthesis standards and multi‑round batch testing ensure consistent high‑purity lyophilized peptides for your research projects.
Global Long‑Term Partnership
We focus on stable cooperation with international buyers, offering flexible MOQ, custom synthesis and competitive factory‑direct pricing.